These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 16809487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT.
    J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
    [Abstract] [Full Text] [Related]

  • 6. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.
    Scherer D, Rachakonda PS, Angelini S, Mehnert F, Sucker A, Egberts F, Hauschild A, Hemminki K, Schadendorf D, Kumar R.
    J Invest Dermatol; 2010 Dec; 130(12):2844-8. PubMed ID: 20720566
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
    Hacker E, Hayward NK, Dumenil T, James MR, Whiteman DC.
    J Invest Dermatol; 2010 Jan; 130(1):241-8. PubMed ID: 19571821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P, Bonelli L, Pastorino L, Bruno W, Barile M, Andreotti V, Nasti S, Battistuzzi L, Grosso M, Bianchi-Scarrà G, Queirolo P.
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [Abstract] [Full Text] [Related]

  • 11. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
    Hacker E, Nagore E, Cerroni L, Woods SL, Hayward NK, Chapman B, Montgomery GW, Soyer HP, Whiteman DC.
    J Invest Dermatol; 2013 Apr; 133(4):1027-33. PubMed ID: 23096702
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms].
    Avilés JA, Lázaro P, Fernández LP, Benítez J, Ibarrola-Villava M, Ribas G.
    Actas Dermosifiliogr; 2012 Apr; 103(1):44-50. PubMed ID: 21737053
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L, Grossman D, Leachman SA.
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.
    Bauer J, Weng J, Kebebew E, Soares P, Trovisco V, Bastian BC.
    Exp Dermatol; 2009 Jun; 18(6):548-52. PubMed ID: 19493000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.